Cathepsin X in serum from patients with colorectal cancer: Relation to prognosis

Radiology and Oncology

Volumn 46, Issue 3, 2012, Pages 207-212

  Vizin, Tjasa ^a   Christensen, Ib ^b   Nielsen, Hans ^c,d   Kos, Janko ^a,e  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b FINSEN LABORATORY   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

cathepsin X; colorectal cancer; cysteine cathepsins; prognosis; serum biomarker

Indexed keywords

CATHEPSIN X;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER PROGNOSIS; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIVERTICULOSIS; ENTERITIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMORRHOID; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RETROSPECTIVE STUDY;

EID: 84867296995     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-012-0040-0     Document Type: Article

References (39)

1. Turk V, Kos J, Turk B. Cysteine cathepsins (proteases)-on the main stage of cancer? Cancer Cell 2004; 5: 409-10. (Pubitemid 38610242)
2. Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies. Radiol Oncol 2008; 42: 69-81. (Pubitemid 351841998)
3. Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S et al. CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids. Radiol Oncol 2011; 45: 102-15.
4. Kos J, Lah TT. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol Rep 1998; 5: 1349-61. (Pubitemid 28474074)
5. Kos J, Sekirnik A, Premzl A, Zavašnik Bergant V, Langerholc T, Turk B, et al. Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues. Exp Cell Res 2005; 306: 103-13. (Pubitemid 40692776)
6. Kos J, Jevnikar Z, Obermajer N. The role of cathepsin X in cell signalling. Cell Adh Migr 2009; 3: 164-6.
7. Obermajer N, Jevnikar Z, Doljak B, Sadaghiani AM, Bogyo M, Kos J. Cathepsin X-mediated β2-integrin activation results in nanotube outgrowth. Cell Mol Life Sci 2009; 66: 1126-34.
8. Nascimento FD, Rizzi CC, Nantes IL, Stefe I, Turk B, Carmona AK, et al. Cathepsin X binds to cell surface heparan sulfate proteoglycans. Arch Biochem Biophys 2005; 436: 323-32. (Pubitemid 40576272)
9. Obermajer N, Repnik U, Jevnikar Z, Turk B, Kreft M, Kos J. Cysteine protease cathepsin X modulates immune response via activation of β2 integrins. Immunology 2008; 124: 76-88. (Pubitemid 351537575)
10. Obermajer N, Doljak B, Jamnik P, Fonovi? UP, Kos J. Cathepsin X cleaves the C-terminal dipeptide of alpha-and gamma-enolase and impairs survival and neuritogenesis of neuronal cells. Int J Biochem Cell Biol 2009; 41: 1685-96.
11. Staudt DN, Aicher KW, Kalbacher H, Stevanovic S, Carmona KA, Bogyo M, et al. Cathepsin X is secreted by human osteoblasts, digests CXCL-12 and impairs adhesion of hematopoietic stem and progenitor cells to osteoblasts. Haematol 2010; 95: 1452-60.
12. Krueger S, Kalinski T, Hundertmark T, Wex T, Küster D, Peitz U, et al. Upregulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer. J Pathol 2005; 207: 32-42. (Pubitemid 41200712)
13. Nägler DK, Lechner AM, Oettl A, Kozaczynska K, Scheuber HP, Gippner-Steppert C, et al. An enzyme-linked immunosorbent assay for human cathepsin X, a potential new inflamatory marker. J Immunol Methods 2006; 308: 241-50. (Pubitemid 43107969)
14. Baker AR, Zalwango S, Malone LL, Igo RP Jr, Qiu F, Nsereko M, et al. Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study. Hum Immunol 2011; 72: 426-30.
15. Ratovitski T, Chiqhladze E, Waldron E, Hirschhorn RR, Ross CA. Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin. J Biol Chem 2011; 286: 12578-89.
16. Hidaka S, Yasutake T, Takeshita H, Kondo M, Tsuji T, Nanashima A, et al. Differences in 20q13.2 Copy Number between Colorectal Cancers with and without liver metastasis. Clin Cancer Res 2000; 6: 2712-7. (Pubitemid 30482109)
17. Bar-Shira A, Pinthus HJ, Rozovsky U, Goldstein M, Sellers RW, Yaron Y, et al. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res 2002; 62: 6803-7. (Pubitemid 35424062)
18. Nägler DK, Krüger S, Kellner A, Ziomek E, Menard R, Buhtz P, et al. Upregulation of Cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. Prostate 2004; 60: 109-19. (Pubitemid 38758576)
19. Rumpler G, Becker B, Hafner C, McClelland M, Stolz W, Landthaler M, et al. Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes. Exp Dermatol 2003; 12: 761-71. (Pubitemid 38028667)
20. Sevenich L, Schurigt U, Sachse K, Gajda M, Werner F, Müller S, et al. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. PNAS 2010; 107: 2497-502.
21. Kraus S, Bunsen T, Schuster S, Cicho? MA, Tacke M, Reinheckel T, et al. Cellular senescence induced by cathepsin X downregulation. Eur J Cell Biol 2011; 90: 678-86.
22. Decock J, Obermajer N, Vozelj S, Hendrickx W, Paridaens R, Kos J. Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer. Int J Biol Markers 2008; 23: 161-8.
23. Kolwijck E, Kos J, Obermajer N, Span PN, Thomas CM, Massuger LF, et al. The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer. Eur J Clin Invest 2010; 40: 591-9.
24. Wang J, Chen L, Li Y, Guan XY. Overexpression of Cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition of hepatocellular carcinoma. PLoS ONE 2011; 6: e24967.
25. Fonovic PU, Kos J. Efficient removal of Cathepsin L from active Cathepsin X using immunoprecipitation technique. Acta Chim 2009; 56: 985-8.
26. Brenner H, Bouvier AM, Foschi R, Hackl M, Larsen IK, Lemmens V, et al. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study. Int J Cancer 2011; doi: 10.1002/ijc.26192.
27. Velenik V. Post-treatment surveillance in colorectal cancer. Radiol Oncol 2010, 44: 135-41.
28. Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009; 15: 5907-15.
29. Booth RA. Minimally invasive biomarkers for detection and staging of colorectal cancer. Cancer Lett 2007; 249: 87-96. (Pubitemid 46437280)
30. Nielsen HJ, Brünner N, Frederiksen C, Lomholt AF, King D, Jørgensen LN, et al. Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection. Scand J Gastroenterol 2008; 43: 242-8. (Pubitemid 351161531)
31. Nielsen HJ, Christensen IJ, Brünner N. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1. Scand J Gastroenterol 2010; 45: 200-7.
32. Obermajer N, Premzl A, Zavašnik Bergant T, Turk B, Kos J. Carboxypeptidase cathepsin X mediates β2-integrin-dependent adhesion of differentiated U-937 cells. Exp Cell Res 2006; 312: 2515-27. (Pubitemid 44036802)
33. Nägler DK, Zhang R, Tam W, Sulea T, Purisima EO, Ménard R. Human cathepsin X: A cysteine protease with unique carboxypeptidase activity. Biochemistry 1999; 38: 12648-54.
34. Vasiljeva O, Papazoglou A, Krüger A, Brodoefel H, Korovin M, Deussing J, et al. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res 2006; 66: 5242-50. (Pubitemid 43844948)
35. Lines KE, Chelala C, Dmitrovic B, Wijesuriya N, Kocher HM, Marshall JF, et al. S100P-binding protein, S100PBP, mediates adhesion through regulation of cathepsin Z in pancreatic cancer cells. Am J Pathol 2012; 180: 1485-94.
36. Nägler DK, Mènard R: Human cathepsin X: a novel cysteine protease of the papain family with a very short proregion and unique insertions. FEBS Lett 1998; 434: 135-9. (Pubitemid 28404676)
37. Santamaría I, Velasco G, Pendás AM, Fueyo A, López-Otín C. Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and unique chromosomal location. J Biol Chem 1998; 273: 16816-23. (Pubitemid 28311709)
38. Hafner A, Obermajer N, Kos J. γ-1-syntrophin mediates trafficking of γ-enolase towards the plasma membrane and enhances its neurotrophic activity. Neurosignals 2010; 18: 246-58.
39. Hafner A, Obermajer N, Kos J. γ-Enolase C-terminal peptide promotes cell survival and neurite ougrowth by activation of PI3K/Akt and MAPK/ERK signalling pathways. Biochem J 2012; 443: 439-50.